Engaged in condomless receptive or insertive anal intercourse or condomless vaginal intercourse in the last 3 months
| Group | Value | 95% CI |
|---|---|---|
| 3T Tune in! Turn on! Turn up! | 49 | |
| General Health Website Materials | 50 |
Last reviewed · How we verify
Evaluation of 3T, a Sex-Positive HIV/STI Mobile App Intervention for Young Black Men Ages 14-19 Attracted to Men
NA trial testing 3T Tune in! Turn on! Turn up! in HIV/AIDS and Infections in 178 participants. Completed in 29 November 2022.
| Lead sponsor | ETR Associates |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 178 |
| Start date | 1 March 2021 |
| Primary completion | 9 November 2022 |
| Estimated completion | 29 November 2022 |
| Sites | 1 location across United States |
ETR Associates
Adults 14 to 19, male only, with HIV/AIDS and Infections or Sexual Behavior. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Engaged in condomless receptive or insertive anal intercourse or condomless vaginal intercourse in the last 3 months
| Group | Value | 95% CI |
|---|---|---|
| 3T Tune in! Turn on! Turn up! | 49 | |
| General Health Website Materials | 50 |
Number of times reported having been tested for STI, including HIV in the last 3 months
| Group | Value | 95% CI |
|---|---|---|
| 3T Tune in! Turn on! Turn up! | 1.04 | ± 1.70 |
| General Health Website Materials | 0.60 | ± 1.36 |
Scale measures beliefs regarding communication with partner about sexual desires/behavior. Average of 6 items on a 5-point scale (1 to 5), with a range of 1 - 5, with a higher score indicating better outcomes
| Group | Value | 95% CI |
|---|---|---|
| 3T Tune in! Turn on! Turn up! | 3.22 | ± 0.62 |
| General Health Website Materials | 3.22 | ± 0.45 |
Scale measures attitudes regarding condoms. Average of 21 items on a 4-point scale (1 to 4), with a range of 1 - 4, with a higher score indicating better outcomes
| Group | Value | 95% CI |
|---|---|---|
| 3T Tune in! Turn on! Turn up! | 3.02 | ± 0.50 |
| General Health Website Materials | 2.90 | ± 0.44 |
Scale measures perceived self-efficacy to use condoms. Average of 4 items on a 4-point scale (1 to 4), with a range of 1 - 4, with a higher score indicating better outcomes
| Group | Value | 95% CI |
|---|---|---|
| 3T Tune in! Turn on! Turn up! | 3.21 | ± 0.69 |
| General Health Website Materials | 3.07 | ± 0.74 |
Scale measures attitudes towards lube. Average of 3 items on a 4-point scale (1-4), with a range of 1-4, with a higher score indicating more positive attitudes towards lube
| Group | Value | 95% CI |
|---|---|---|
| 3T Tune in! Turn on! Turn up! | 3.40 | ± 0.63 |
| General Health Website Materials | 3.40 | ± 0.60 |
This study features a 2-arm randomized controlled trial with approximately 300 young black men who have sex with men (YBMSM) to assess the effectiveness of the 3T mobile app. To be eligible participants will be required to identify as male; Black, African-American, or biracial Black/African American; age 14-19 at baseline; self-identify as gay, bisexual, fluid, or sexually attracted to men; own a smartphone, and reside in any state in the United States. Those in the treatment arm will be provided with the 3T app and those in the control group will be given access to a website with general health materials. Participants will complete brief online surveys at baseline and at 3-months following the baseline to assess effectiveness in changing sexual risk behaviors and communication and condom use behaviors and attitudes.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04135443.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing